Overview
| Alternate Names: | FPP synthetase; OTTHUMP00000015807; OTTHUMP00000015808; farnesyl diphosphate synthase |
|---|---|
| Alternate Symbols: | FPPS; FPS |
| PharmGKB Accession Id: | PA28075 |
Details
| Cytogenetic Location: | chr1 : q22 |
|---|---|
| GP mRNA Boundary†: | chr1 : 153545374 - 153557080 |
| GP Gene Boundary†: | chr1 : 153535374 - 153560080 |
| Strand: | plus |
| Product Name: | farnesyl diphosphate synthase, farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase) |
†
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped
onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries
by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for
potential regulatory regions.
Curated Annotations (
)
-
rs2297480
at chr1:153546106
in
FDPS,
PKLR
This variant impacted the response to long-term N-bisphosphonates treatment in a study of 234 Danish postmenopausal women. Patients with the homozygous CC genotype showed a decreased response of bone turnover markers to amino-bisphosphonate therapy.- Related Drugs:
- alendronate, ibandronate, pamidronate, risedronate, zoledronate
- Related Diseases:
- Osteoporosis, Osteoporosis, Postmenopausal
- Evidence:
-
PMID:18687167
Variant names are different names that have been used in the literature and other resources to
refer to the same variant.
Non-Curated Information
A list of non-curated publications that mention this gene along with other genes is available.
PharmGKB Curated Pathways
Curated Information
The following drugs are in curated knowledge about this gene.
| Drug | Relationship | Evidence | |
|---|---|---|---|
|
|
alendronate |
|
Publications, Variants |
|
|
ibandronate |
|
Publications, Variants |
|
|
pamidronate |
|
Publications, Variants |
|
|
risedronate |
|
Publications, Variants |
|
|
zoledronate |
|
Publications, Variants |
Non-Curated Information
A list of non-curated publications that mention this gene along with other drugs is available.
Curated Information
The following diseases are in curated knowledge about this gene.
| Disease | Relationship | Evidence | |
|---|---|---|---|
|
|
Hypercalcemia |
|
Publications |
|
|
Osteogenesis Imperfecta |
|
Publications |
|
|
Osteoporosis |
|
Publications, Variants |
|
|
Osteoporosis, Postmenopausal |
|
Publications, Variants |
LinkOuts
- Entrez Gene ID:
- 2224
- OMIM Accession:
- 134629
- UCSC Genome Browser ID:
- NM_002004
- Ref Seq NM Accession:
- NM_001135821
- NM_001135822
- NM_002004
- Ref Seq NP Accession:
- AAA35820
- AAA52423
- AAH10004
- ABM84397
- ABM86869
- BAA03523
- BAF83773
- BAG51125
- CAI12715
- EAW53075
- EAW53076
- EAW53077
- EAW53078
- NP_001129293
- NP_001129294
- NP_001995
- P14324
- Ref Seq NT Accession:
- AC_000044
- AC_000133
- NC_000001
- NT_004487
- NW_001838531
- NW_925683
- UniProtKB Accesssion:
- FPPS_HUMAN (P14324)
- Ensembl ID:
- ENSG00000160752
- GenAtlas ID:
- FDPS
- GeneCard ID:
- FDPS
Common Searches
Non-Curated Publications
A list of non-curated publications that mention this gene is available.
